Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of its performance and outlook.

Niva Bupa Health has experienced a revision in its market evaluation, reflecting shifts in its financial and technical outlook. The insurance company’s recent assessment highlights a complex interplay of valuation concerns, subdued financial performance, and technical indicators that have influenced investor sentiment.

Niva Bupa Health Insurance Company is currently exhibiting a shift in price momentum, with technical indicators signalling a bearish trend across multiple timeframes. The stock’s recent trading activity and comparative returns against the Sensex highlight a challenging environment for the insurance sector player as it navigates evolving market dynamics.

Niva Bupa Health's market evaluation has undergone a revision reflecting shifts in its financial and technical outlook, with recent data indicating subdued profitability and valuation concerns within the insurance sector.

Niva Bupa Health Insurance Company’s stock has exhibited a complex technical profile in recent weeks, reflecting a nuanced shift in price momentum and market sentiment. While some indicators suggest cautious optimism, others point to persistent challenges, underscoring the importance of a detailed technical analysis for investors navigating the insurance sector.

Niva Bupa Health Insurance Company Ltd. reported a net loss of ₹35.27 crores for Q2 FY26, marking a sharp deterioration from the ₹13.02 crore profit posted in Q2 FY25. Despite robust premium growth of 17.21% year-on-year, the health insurer's inability to control operational expenses has raised serious concerns about the sustainability of its business model. The stock, trading at ₹74.20 with a market capitalisation of ₹13,633 crores, has declined 1.60% following the results, extending its year-to-date losses to 11.50%.

Niva Bupa Health Insurance Company has recently revised its evaluation amid challenging market conditions. The stock is currently priced at 74.86, reflecting a year-to-date decline of 10.71%. Technical indicators suggest a bearish sentiment, while the stock has fluctuated between a 52-week high of 109.41 and a low of 61.01.

Niva Bupa Health Insurance Company has shown strong performance, gaining significantly and outperforming its sector. The stock has risen consistently over four days, trading above key moving averages. In the broader market, the Sensex has also seen positive movement, with small-cap stocks leading the gains.

Niva Bupa Health Insurance Company's stock has seen a notable decline today, underperforming compared to the broader sector. The stock is currently above its 200-day moving average but below several shorter-term averages. Meanwhile, the broader market, represented by the Sensex, has also opened lower.